NCT06183619View on ClinicalTrials.gov

Superior Vena Cava Isolation Plus Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

Active, not recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

May 31, 2025

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Pulmonary vein isolation plus superior vena cava isolation

Pulmonary vein isolation plus superior vena cava isolation

PROCEDURE

Pulmonary vein isolation

Pulmonary vein isolation only

Trial Locations (1)

100037

Chinese Academy of Medical Science, Fuwai hospital, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

NCT06183619 - Superior Vena Cava Isolation Plus Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter